A discovery that may result in novel medicines to halt or reverse the disease could be beneficial to patients with a rare genetic bone marrow problem who are at an elevated risk of blood malignancies.
Despite the fact that chimeric antigen receptor T-cell (CAR-T) therapy has transformed cancer treatment, few studies have looked into its impact on long-term patient quality of life - an aspect of care that is frequently compromised when patients receive traditional intensive cancer medicati
The spongy tissue found inside bones called bone marrow is in charge of producing platelets, white blood cells, and red blood cells. Anemia, blood malignancies, and dangerous infections are all more likely to occur as a result of bone marrow failure syndromes.